ArticleNoro psikiyatri arsivi2025
Sleep Disorders in Patients with Epilepsy.
Article in Noro psikiyatri arsivi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Targeting Modifiable Risks: Molecular Mechanisms and Population Burden of Lifestyle Factors on Male Genitourinary Health.International journal of molecular sciences · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aims to investigate obstructive sleep apnoea syndrome (OSAS), quality of sleep, excessive daytime sleepiness (EDS) and quality of life in patients with epilepsy. Methods: One hundred and eleven epilepsy patients, diagnosed with ILAE (international league against epilepsy) criteria, were included in this study. The mean age of the patients was 37.6 ±13.1 (19-77) years. Fifty-four of the patients were (48.6%) men and 57 were (51.5%) women. Age, gender, education level, body mass index, seizure frequency, types of seizures, electroencephalography (EEG) findings, seizures during sleep, and number of anti-seizure drugs were recorded. Berlin Questionnaire (BQ) was used to screen OSAS. Sleep and quality of life were assessed with Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS) and Quality of Life in Epilepsy-31(QOLIE-31) scales. Results: Thirty-six percent of the patients' quality of sleep was poor and 20.7% had mild EDS. Low risk of OUAS was found in 89.2% of the patients. Quality of life was poor according to QOLIE-31. QOLIE 31 and PSQI total score had a statistically significant low negative correlation with BQ. PSQI total score had a statistically significant, low negative correlation with QOLIE-31. Poor sleep quality, EDS, OUAS and quality of life showed no correlation with demographic features, duration of disease, types of seizures, seizure frequency, number of anti-seizure drugs. Conclusion: The poor quality of sleep was 36% in our study. Poor quality of sleep, excessive daytime sleepiness and obstructive sleep apnoea syndrome had no correlation with the demographic and clinical features of the patients with epilepsy but showed low correlation with quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.